ETV Telangana | Minister Lakshma will inaugurate the D.Med’s Dialysis Clinic in the Gandhi Hospital of Secunderabad, India
Meet us at the 54th ERA-EDTA, the world’s largest event for the medical sector in the field of dialysis, from June 3rd-6th 2017Read more
D.Med Healthcare GmbH & Co. KG and Changshan Pharmaceutical (Hongkong) Co. Ltd., 100% subsidiary of the stock-listed Chinese manufacturer of pharmaceutical products, Hebei Changshan Biomedical Pharmaceutical Co. Ltd. (Shenzhen Stock Exchange / SIN 300255:CH), announce the set-up of a joint venture aiming at the production and marketing of Heparin formulations
In order to strengthen its role in the production, sales, marketing and further development of the highly innovative Gynedil dilation devices (www.gynedil.com), D.Med Healthcare AG has increased its share in Belgrade-based Inove d.o.o., the manufacturer of Gynedil, from 10 to 54.5% by taking over the shares of the company’s founder Dobrivoje Rajkovic. This deal underlines the importance of the Gynaecology segment in D.Med’s future strategy and will be followed by further steps in this field.